Nath Bio-Genes

26
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Other Agricultural Products
  • ISIN: INE448G01010
  • NSEID: NATHBIOGEN
  • BSEID: 537291
INR
142.45
-3.4 (-2.33%)
BSENSE

Dec 05

BSE+NSE Vol: 59.02 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Nath Bio-Genes Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'13
Mar'12
No of Months
12
12
12
12
12
12
Profit Before Tax
40.00
41.00
36.00
-63.00
12.30
0.00
Adjustment
13.00
10.00
12.00
102.00
8.18
0.00
Changes In working Capital
-34.00
23.00
-9.00
-18.00
-5.72
0.00
Cash Flow after changes in Working Capital
18.00
74.00
39.00
19.00
14.76
0.00
Cash Flow from Operating Activities
17.00
74.00
38.00
17.00
14.21
0.00
Cash Flow from Investing Activities
-3.00
-27.00
-2.00
-19.00
-20.77
0.00
Cash Flow from Financing Activities
-2.00
-7.00
-1.00
-22.00
5.74
0.00
Net Cash Inflow / Outflow
11.00
39.00
33.00
-25.00
-0.81
0.00
Opening Cash & Cash Equivalents
77.00
38.00
4.00
29.00
3.29
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
88.00
77.00
38.00
4.00
2.48
0.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Nath Bio-Genes
Markets Mojo
Figures in Cr
standaloned Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
44.12
9.33
35.00
372.88%
Adjustment
12.17
3.17
9.00
283.91%
Changes In working Capital
-28.41
-14.54
-14.00
-95.39%
Cash Flow after changes in Working Capital
27.88
-2.04
29.00
1466.67%
Cash Flow from Operating Activities
26.8
-4.31
30.00
721.81%
Cash Flow from Investing Activities
-4.05
-3.43
-1.00
-18.08%
Cash Flow from Financing Activities
-10.62
6.98
-16.00
-252.15%
Net Cash Inflow / Outflow
12.13
-0.77
12.00
1675.32%
Opening Cash & Cash Equivalents
75.5
0.88
75.00
8479.55%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
87.63
0.11
87.00
79563.64%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is -76.43% vs 94.40% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
17.58
74.59
-76.43%